Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Combination therapy was also associated with a lower risk of all-cause mortality (RR 0.50 [95% CI 0.40, 0.63]
It is not currently approved or indicated for any condition in the UK
Eliquis IP Valuation The Orange Book listing for apixaban includes the compound patent (estimated expiry 2026 after PTE), two formulation patents with estimated expiry in 2028, and a method-of-use patent for atrial fibrillation
Keep a diary of your energy levels, sleep patterns, and any changes in your weight
US$ 26.63
US$ 27.43
US$ 27.77
US$ 23.98
